Knight Therapeutics | GUD - Trade Creditors

Stock Price
6.17
Daily Change
0.02 0.33%
Monthly
-4.93%
Yearly
-1.28%
Q1 Forecast
5.95

Knight Therapeutics reported CAD118.13M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acasti Pharma USD 459K 881K Sep/2025
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Aurora Cannabis CAD 49.34M 31.94M Sep/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Canopy Growth CAD 18.14M 5.94M Sep/2025
Cronos Group USD 11.64M 775K Dec/2025
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Knight Therapeutics CAD 118.13M 8.16M Sep/2025
Moderna USD 317M 50M Dec/2025
Omeros USD 8.84M 4.42M Jun/2025
Organigram Holdings CAD 89.25M 556K Sep/2025
Organon & Co USD 1.07B 7M Sep/2025
Revvity USD 185.46M 9.66M Dec/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Tilray USD 107.35M 8.43M Mar/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 6.53M 2.93M Sep/2025